{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:53:03Z","timestamp":1761630783650},"reference-count":104,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","surgpath.theclinics.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.path.2017.01.005","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T23:45:31Z","timestamp":1489880731000},"page":"299-317","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advances in the Genetic Characterization of Cutaneous Mesenchymal Neoplasms"],"prefix":"10.1016","volume":"10","author":[{"given":"Leigh A.","family":"Compton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leona A.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.path.2017.01.005_bib1","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/1097-0142(19920315)69:6<1382::AID-CNCR2820690614>3.0.CO;2-Y","article-title":"The fibroma-like variant of epithelioid sarcoma. A fibrohistiocytic\/myoid cell lesion often confused with benign and malignant spindle cell tumors","volume":"69","author":"Mirra","year":"1992","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.path.2017.01.005_bib2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/PAS.0b013e3181ff0901","article-title":"Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior","volume":"35","author":"Hornick","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2017.01.005_bib3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/his.12310","article-title":"Rarely metastasizing soft tissue tumours","volume":"64","author":"Mangham","year":"2014","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.path.2017.01.005_bib4","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/PAS.0b013e3181882c54","article-title":"Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma","volume":"33","author":"Hornick","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2017.01.005_bib5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cancergen.2011.01.002","article-title":"Translocation t(7;19)(q22;q13)\u2212a recurrent chromosome aberration in pseudomyogenic hemangioendothelioma?","volume":"204","author":"Trombetta","year":"2011","journal-title":"Cancer Genet"},{"issue":"5","key":"10.1016\/j.path.2017.01.005_bib6","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/path.4322","article-title":"A\u00a0novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma","volume":"232","author":"Walther","year":"2014","journal-title":"J\u00a0Pathol"},{"issue":"1","key":"10.1016\/j.path.2017.01.005_bib7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13000-016-0530-2","article-title":"Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics","volume":"11","author":"Sugita","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.path.2017.01.005_bib8","article-title":"FOSB is a useful diagnostic marker for pseudomyogenic hemangioendothelioma","author":"Hung","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2017.01.005_bib9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1136\/jcp.44.2.139","article-title":"Distribution of plasminogen activator inhibitor (PAI-1) in tissues","volume":"44","author":"Simpson","year":"1991","journal-title":"J\u00a0Clin Pathol"},{"issue":"4","key":"10.1016\/j.path.2017.01.005_bib10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1055\/s-0033-1334487","article-title":"Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin","volume":"39","author":"Declerck","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"16","key":"10.1016\/j.path.2017.01.005_bib11","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.ejca.2005.08.008","article-title":"The Fos family of transcription factors and their role in tumourigenesis","volume":"41","author":"Milde-Langosch","year":"2005","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.path.2017.01.005_bib12","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cellsig.2009.12.008","article-title":"AP-1\u2013The Jun proteins: Oncogenes or tumor suppressors in disguise?","volume":"22","author":"Shaulian","year":"2010","journal-title":"Cell Signal"},{"issue":"9","key":"10.1016\/j.path.2017.01.005_bib13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/79683","article-title":"Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis","volume":"6","author":"Sabatakos","year":"2000","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.path.2017.01.005_bib14","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1091\/mbc.E07-08-0768","article-title":"Antagonistic regulation of cell-matrix adhesion by FosB and DeltaFosB\/Delta2DeltaFosB encoded by alternatively spliced forms of fosB transcripts","volume":"19","author":"Ohnishi","year":"2008","journal-title":"Mol Biol Cell"},{"issue":"5","key":"10.1016\/j.path.2017.01.005_bib15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1359\/jbmr.080110","article-title":"Doubly truncated FosB isoform (Delta2DeltaFosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity","volume":"23","author":"Sabatakos","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"issue":"10","key":"10.1016\/j.path.2017.01.005_bib16","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1097\/PAS.0000000000000469","article-title":"Frequent FOS gene rearrangements in epithelioid hemangioma: a molecular study of 58 cases with morphologic reappraisal","volume":"39","author":"Huang","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.path.2017.01.005_bib17","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/gcc.22206","article-title":"ZFP36-FOSB fusion defines a subset of epithelioid hemangioma with atypical features","volume":"53","author":"Antonescu","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.path.2017.01.005_bib18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/01.cco.0000432522.16734.2d","article-title":"WHO classification of soft tissue and bone, fourth edition: summary and commentary","volume":"25","author":"Rosenberg","year":"2013","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"10.1016\/j.path.2017.01.005_bib19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/PAT.0000000000000050","article-title":"WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition","volume":"46","author":"Jo","year":"2014","journal-title":"Pathology"},{"issue":"4","key":"10.1016\/j.path.2017.01.005_bib20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/00000478-199704000-00001","article-title":"Epithelioid hemangioendothelioma of skin and soft tissues: clinicopathologic and immunohistochemical study of 30 cases","volume":"21","author":"Mentzel","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2017.01.005_bib21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/00000372-199812000-00001","article-title":"Epithelioid hemangioendothelioma presenting in the skin: a clinicopathologic study of eight cases","volume":"20","author":"Quante","year":"1998","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1016\/j.path.2017.01.005_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1600-0560.2007.00790.x","article-title":"Cutaneous epithelioid hemangioendothelioma","volume":"35","author":"Clarke","year":"2008","journal-title":"J\u00a0Cutan Pathol"},{"issue":"5","key":"10.1016\/j.path.2017.01.005_bib23","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/1097-0142(19820901)50:5<970::AID-CNCR2820500527>3.0.CO;2-Z","article-title":"Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma","volume":"50","author":"Weiss","year":"1982","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.path.2017.01.005_bib24","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/PAS.0b013e31815bf8e6","article-title":"Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases","volume":"32","author":"Deyrup","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.path.2017.01.005_bib25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/00000478-200108000-00011","article-title":"Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics","volume":"25","author":"Folpe","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2017.01.005_bib26","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/PAS.0b013e318206b67b","article-title":"ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma","volume":"35","author":"Miettinen","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.path.2017.01.005_bib27","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1097\/00000478-199611000-00001","article-title":"Epithelioid hemangioendothelioma of bone","volume":"20","author":"Kleer","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2017.01.005_bib28","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<562::AID-CNCR7>3.0.CO;2-T","article-title":"Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases","volume":"85","author":"Makhlouf","year":"1999","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.path.2017.01.005_bib29","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1053\/hupa.2000.9843","article-title":"Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: implications in tumor diagnosis","volume":"31","author":"Miettinen","year":"2000","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.path.2017.01.005_bib30","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/00000478-200105000-00019","article-title":"Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma","volume":"25","author":"Mendlick","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"98","key":"10.1016\/j.path.2017.01.005_bib31","doi-asserted-by":"publisher","first-page":"98ra82","DOI":"10.1126\/scitranslmed.3002409","article-title":"Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma","volume":"3","author":"Tanas","year":"2011","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.path.2017.01.005_bib32","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/gcc.20886","article-title":"A\u00a0novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites","volume":"50","author":"Errani","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.path.2017.01.005_bib33","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/his.12697","article-title":"Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants","volume":"67","author":"Patel","year":"2015","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.path.2017.01.005_bib34","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/jcp.22435","article-title":"The Hippo pathway in biological control and cancer development","volume":"226","author":"Chan","year":"2011","journal-title":"J\u00a0Cell Physiol"},{"issue":"8","key":"10.1016\/j.path.2017.01.005_bib35","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1158\/0008-5472.CAN-07-2696","article-title":"A\u00a0role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells","volume":"68","author":"Chan","year":"2008","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.path.2017.01.005_bib36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1158\/1940-6207.CAPR-10-0025","article-title":"A\u00a0migration signature and plasma biomarker panel for pancreatic adenocarcinoma","volume":"4","author":"Balasenthil","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"issue":"7","key":"10.1016\/j.path.2017.01.005_bib37","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1128\/MCB.01874-07","article-title":"TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway","volume":"28","author":"Lei","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"24","key":"10.1016\/j.path.2017.01.005_bib38","doi-asserted-by":"publisher","first-page":"21851","DOI":"10.1074\/jbc.M200268200","article-title":"A\u00a0novel family of calmodulin-binding transcription activators in multicellular organisms","volume":"277","author":"Bouche","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.path.2017.01.005_bib39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/PAS.0000000000000511","article-title":"Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics","volume":"40","author":"Doyle","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.path.2017.01.005_bib40","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/gcc.22073","article-title":"Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma","volume":"52","author":"Antonescu","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.path.2017.01.005_bib41","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1038\/modpathol.2013.176","article-title":"Malignant vascular tumors\u2013an update","volume":"27","author":"Antonescu","year":"2014","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.path.2017.01.005_bib42","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1093\/hmg\/5.9.1333","article-title":"The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene","volume":"5","author":"Sidhar","year":"1996","journal-title":"Hum Mol Genet"},{"issue":"18","key":"10.1016\/j.path.2017.01.005_bib43","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/sj.onc.1201394","article-title":"Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma","volume":"15","author":"Clark","year":"1997","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.path.2017.01.005_bib44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0002-9440(10)61684-7","article-title":"Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents","volume":"159","author":"Argani","year":"2001","journal-title":"Am J Pathol"},{"issue":"34","key":"10.1016\/j.path.2017.01.005_bib45","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1038\/sj.onc.1206686","article-title":"A\u00a0novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23)","volume":"22","author":"Argani","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.path.2017.01.005_bib46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/sj.onc.1204074","article-title":"The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25","volume":"20","author":"Ladanyi","year":"2001","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.path.2017.01.005_bib47","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/modpathol.3880221","article-title":"Hemosiderotic fibrohistiocytic lipomatous lesion: ten cases of a previously undescribed fatty lesion of the foot\/ankle","volume":"13","author":"Marshall-Taylor","year":"2000","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.path.2017.01.005_bib48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1365-2559.2006.02360.x","article-title":"Haemosiderotic fibrolipomatous tumour (so-called haemosiderotic fibrohistiocytic lipomatous tumour): analysis of 13 new cases in support of a distinct entity","volume":"48","author":"Browne","year":"2006","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.path.2017.01.005_bib49","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/path.2513","article-title":"Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions","volume":"217","author":"Hallor","year":"2009","journal-title":"J\u00a0Pathol"},{"issue":"10","key":"10.1016\/j.path.2017.01.005_bib50","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/gcc.20897","article-title":"Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor","volume":"50","author":"Antonescu","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.path.2017.01.005_bib51","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1182\/blood.V99.5.1776","article-title":"Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13)","volume":"99","author":"Cools","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.path.2017.01.005_bib52","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ydbio.2005.09.011","article-title":"Functions and regulations of fibroblast growth factor signaling during embryonic development","volume":"287","author":"Thisse","year":"2005","journal-title":"Developmental Biol"},{"issue":"5","key":"10.1016\/j.path.2017.01.005_bib53","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1210\/en.2005-1502","article-title":"Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8","volume":"147","author":"Valta","year":"2006","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.path.2017.01.005_bib54","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1158\/1078-0432.CCR-04-2057","article-title":"Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy","volume":"11","author":"Ishibe","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.path.2017.01.005_bib55","first-page":"2053","article-title":"High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8","volume":"58","author":"Tanaka","year":"1998","journal-title":"Cancer Res"},{"issue":"3\u20134","key":"10.1016\/j.path.2017.01.005_bib56","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cytogfr.2007.04.010","article-title":"Role of fibroblast growth factor 8 in growth and progression of hormonal cancer","volume":"18","author":"Mattila","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"issue":"8\u20139","key":"10.1016\/j.path.2017.01.005_bib57","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1387\/ijdb.103080cf","article-title":"Vestigial like gene family expression in Xenopus: common and divergent features with other vertebrates","volume":"54","author":"Faucheux","year":"2010","journal-title":"Int J Dev Biol"},{"issue":"2","key":"10.1016\/j.path.2017.01.005_bib58","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1194\/jlr.M032755","article-title":"Vestigial-like 3 is an inhibitor of adipocyte differentiation","volume":"54","author":"Halperin","year":"2013","journal-title":"J\u00a0Lipid Res"},{"issue":"9","key":"10.1016\/j.path.2017.01.005_bib59","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1097\/PAS.0000000000000212","article-title":"TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms","volume":"38","author":"Carter","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.path.2017.01.005_bib60","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1097\/PAS.0b013e3181f17d51","article-title":"Hybrid myxoinflammatory fibroblastic sarcoma\/hemosiderotic fibrolipomatous tumor: report of a case providing further evidence for a pathogenetic link","volume":"34","author":"Elco","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.path.2017.01.005_bib61","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/00000478-199808000-00001","article-title":"Acral myxoinflammatory fibroblastic sarcoma: a low-grade tumor of the hands and feet","volume":"22","author":"Meis-Kindblom","year":"1998","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2017.01.005_bib62","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S1092-9134(02)00022-9","article-title":"Myxoinflammatory fibroblastic sarcoma: a tumor not restricted to acral sites","volume":"6","author":"Jurcic","year":"2002","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"10.1016\/j.path.2017.01.005_bib63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00000478-199601000-00002","article-title":"Pleomorphic hyalinizing angiectatic tumor of soft parts. A low-grade neoplasm resembling neurilemoma","volume":"20","author":"Smith","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.path.2017.01.005_bib64","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1097\/01.pas.0000141406.02581.fb","article-title":"Pleomorphic hyalinizing angiectatic tumor: analysis of 41 cases supporting evolution from a distinctive precursor lesion","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2017.01.005_bib65","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.biocel.2014.03.027","article-title":"Fusions involving protein kinase C and membrane-associated proteins in benign fibrous histiocytoma","volume":"53","author":"P\u0142aszczyca","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"issue":"9","key":"10.1016\/j.path.2017.01.005_bib66","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/labinvest.2015.83","article-title":"Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing","volume":"95","author":"Walther","year":"2015","journal-title":"Lab Invest"},{"key":"10.1016\/j.path.2017.01.005_bib67","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/978-94-007-2888-2_28","article-title":"The biology of protein kinase C","volume":"740","author":"Zeng","year":"2012","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.path.2017.01.005_bib68","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1365-2133.1989.tb07782.x","article-title":"Epithelioid cell histiocytoma: a new entity","volume":"120","author":"Jones","year":"1989","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.path.2017.01.005_bib69","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/modpathol.2015.49","article-title":"ALK rearrangement and overexpression in epithelioid fibrous histiocytoma","volume":"28","author":"Doyle","year":"2015","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.path.2017.01.005_bib70","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/cup.12352","article-title":"Atypical fibrous histiocytoma of the skin with CD30 and p80\/ALK1 positivity and ALK gene rearrangement","volume":"41","author":"Szablewski","year":"2014","journal-title":"J\u00a0Cutan Pathol"},{"issue":"5","key":"10.1016\/j.path.2017.01.005_bib71","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/bjd.13548","article-title":"Epithelioid cell histiocytoma of the skin with clonal ALK gene rearrangement resulting in VCL-ALK and SQSTM1-ALK gene fusions","volume":"172","author":"Jedrych","year":"2015","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.path.2017.01.005_bib72","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2559.1994.tb01290.x","article-title":"Epithelioid benign fibrous histiocytoma of skin: clinico-pathological analysis of 20 cases of a poorly known variant","volume":"24","author":"Singh Gomez","year":"1994","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.path.2017.01.005_bib73","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/PAS.0b013e31827070d4","article-title":"Metastasizing \u201cbenign\u201d cutaneous fibrous histiocytoma: a clinicopathologic analysis of 16 cases","volume":"37","author":"Doyle","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2017.01.005_bib74","first-page":"583","article-title":"Epithelioid cell histiocytoma. A report of 10 cases including a new cellular variant","volume":"18","author":"Glusac","year":"1994","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2017.01.005_bib75","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1600-0560.2011.01747.x","article-title":"EMA positivity in epithelioid fibrous histiocytoma: a potential diagnostic pitfall","volume":"38","author":"Doyle","year":"2011","journal-title":"J\u00a0Cutan Pathol"},{"issue":"1","key":"10.1016\/j.path.2017.01.005_bib76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000372-199902000-00001","article-title":"Epithelioid cell histiocytoma: a simulant of vascular and melanocytic neoplasms","volume":"21","author":"Glusac","year":"1999","journal-title":"Am J Dermatopathol"},{"issue":"8","key":"10.1016\/j.path.2017.01.005_bib77","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1600-0560.2012.01944.x","article-title":"Desmin and CD34 positivity in cellular fibrous histiocytoma: an immunohistochemical analysis of 100 cases","volume":"39","author":"Volpicelli","year":"2012","journal-title":"J\u00a0Cutan Pathol"},{"issue":"2","key":"10.1016\/j.path.2017.01.005_bib78","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/00000372-199004000-00003","article-title":"Cell differentiation in benign cutaneous fibrous histiocytomas. An immunohistochemical study with antibodies to histiomonocytic cells and intermediate filament proteins","volume":"12","author":"Soini","year":"1990","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.path.2017.01.005_bib79","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1038\/ncomms4116","article-title":"Kinase fusions are frequent in Spitz tumours and spitzoid melanomas","volume":"5","author":"Wiesner","year":"2014","journal-title":"Nat Commun"},{"issue":"5151","key":"10.1016\/j.path.2017.01.005_bib80","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma","volume":"263","author":"Morris","year":"1994","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.path.2017.01.005_bib81","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0002-9440(10)64550-6","article-title":"TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors","volume":"157","author":"Lawrence","year":"2000","journal-title":"Am J Pathol"},{"issue":"7215","key":"10.1016\/j.path.2017.01.005_bib82","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nature07397","article-title":"Activating mutations in ALK provide a therapeutic target in neuroblastoma","volume":"455","author":"George","year":"2008","journal-title":"Nature"},{"issue":"7215","key":"10.1016\/j.path.2017.01.005_bib83","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nature07399","article-title":"Oncogenic mutations of ALK kinase in neuroblastoma","volume":"455","author":"Chen","year":"2008","journal-title":"Nature"},{"issue":"7215","key":"10.1016\/j.path.2017.01.005_bib84","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature07398","article-title":"Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma","volume":"455","author":"Janoueix-Lerosey","year":"2008","journal-title":"Nature"},{"issue":"7215","key":"10.1016\/j.path.2017.01.005_bib85","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nature07261","article-title":"Identification of ALK as a major familial neuroblastoma predisposition gene","volume":"455","author":"Mosse","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.path.2017.01.005_bib86","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/00000478-199701000-00002","article-title":"Mixed tumors and myoepitheliomas of soft tissue: a clinicopathologic study of 19 cases with a unifying concept","volume":"21","author":"Kilpatrick","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2017.01.005_bib87","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1097\/00000478-200309000-00001","article-title":"Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters","volume":"27","author":"Hornick","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2017.01.005_bib88","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/gcc.22063","article-title":"Frequent PLAG1 gene rearrangements in skin and soft tissue myoepithelioma with ductal differentiation","volume":"52","author":"Antonescu","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.path.2017.01.005_bib89","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/gcc.20938","article-title":"A\u00a0subset of cutaneous and soft tissue mixed tumors are genetically linked to their salivary gland counterpart","volume":"51","author":"Bahrami","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.path.2017.01.005_bib90","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00428-011-1149-z","article-title":"PLAG1 expression in cutaneous mixed tumors: an immunohistochemical and molecular genetic study","volume":"459","author":"Matsuyama","year":"2011","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.path.2017.01.005_bib91","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.humpath.2003.08.016","article-title":"Cutaneous myoepithelioma: a clinicopathologic and immunohistochemical study of 14 cases","volume":"35","author":"Hornick","year":"2004","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.path.2017.01.005_bib92","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1097\/PAS.0b013e3182772bba","article-title":"Cutaneous syncytial myoepithelioma: clinicopathologic characterization in a series of 38 cases","volume":"37","author":"Jo","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2017.01.005_bib93","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cncr.22380","article-title":"Clear cell sarcoma of tendons and aponeuroses: a study of 75 patients","volume":"109","author":"Kawai","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.path.2017.01.005_bib94","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/1097-0142(196509)18:9<1163::AID-CNCR2820180916>3.0.CO;2-0","article-title":"Clear-cell sarcoma of tendons and aponeuroses. An analysis of 21 cases","volume":"18","author":"Enzinger","year":"1965","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.path.2017.01.005_bib95","first-page":"22","article-title":"Clear cell sarcoma of tendons and aponeuroses with melanin","volume":"95","author":"Hoffman","year":"1973","journal-title":"Arch Pathol"},{"issue":"4","key":"10.1016\/j.path.2017.01.005_bib96","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0344-0338(79)80034-5","article-title":"Clear cell sarcoma of tendons and aponeuroses: malignant melanoma of soft tissues? Report of four cases","volume":"165","author":"Ekfors","year":"1979","journal-title":"Pathol Res Pract"},{"issue":"5","key":"10.1016\/j.path.2017.01.005_bib97","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/00000478-198307000-00003","article-title":"Malignant melanoma of soft parts. A reassessment of clear cell sarcoma","volume":"7","author":"Chung","year":"1983","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2017.01.005_bib98","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/1097-0142(197509)36:3<977::AID-CNCR2820360321>3.0.CO;2-D","article-title":"Clear cell sarcoma with melanin pigment","volume":"36","author":"Bearman","year":"1975","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.path.2017.01.005_bib99","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/PAS.0b013e31814b18fb","article-title":"Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases","volume":"32","author":"Hisaoka","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2017.01.005_bib100","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/modpathol.3880249","article-title":"Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation","volume":"14","author":"Granter","year":"2001","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.path.2017.01.005_bib101","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ijc.10404","article-title":"Molecular genetic characterization of the EWS\/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses","volume":"99","author":"Panagopoulos","year":"2002","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.path.2017.01.005_bib102","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/cncr.22099","article-title":"Diagnosis of\u00a0clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissues: clinicopathologic and molecular analysis of 44 patients from the French sarcoma group","volume":"107","author":"Coindre","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.path.2017.01.005_bib103","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S1525-1578(10)60679-4","article-title":"Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases","volume":"4","author":"Antonescu","year":"2002","journal-title":"J\u00a0Mol Diagn"},{"issue":"9","key":"10.1016\/j.path.2017.01.005_bib104","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/modpathol.2009.85","article-title":"Detection and characterization of EWSR1\/ATF1 and EWSR1\/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts)","volume":"22","author":"Wang","year":"2009","journal-title":"Mod Pathol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918117300181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918117300181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T03:29:19Z","timestamp":1719113359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918117300181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1875918117300181"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2017.01.005","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the Genetic Characterization of Cutaneous Mesenchymal Neoplasms","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2017.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}